Comerica Bank’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.45K | Buy |
315
+53
| +20% | +$917 | ﹤0.01% | 3354 |
|
|
2025
Q1 | $5.73K | Sell |
262
-286
| -52% | -$6.26K | ﹤0.01% | 3300 |
|
|
2024
Q4 | $17.5K | Sell |
548
-1,261
| -70% | -$40.2K | ﹤0.01% | 3066 |
|
|
2024
Q3 | $52.2K | Sell |
1,809
-6,546
| -78% | -$189K | ﹤0.01% | 2787 |
|
|
2024
Q2 | $321K | Buy |
8,355
+192
| +2% | +$7.37K | ﹤0.01% | 2041 |
|
|
2024
Q1 | $480K | Buy |
8,163
+6,804
| +501% | +$400K | ﹤0.01% | 1888 |
|
|
2023
Q4 | $81.3K | Sell |
1,359
-94,820
| -99% | -$5.68M | ﹤0.01% | 2572 |
|
|
2023
Q3 | $3.66M | Buy |
+96,179
| New | +$3.66M | 0.02% | 771 |
|
|
2022
Q4 | $3.45M | Buy |
+66,230
| New | +$3.45M | 0.03% | 765 |
|